MarketPeel
Insider Trading Intelligence
JH

James Herriott

EXAS
SVP, GENERAL COUNSEL & SEC · EXACT SCIENCES CORP · CIK 0001957680
FILING MIX · LIFETIME39%/61%
BUYS
33
SELLS
52
TOTAL VALUE
$6.34M
COMPANIES
1
ACTIVE SINCE
Feb 2023
HOLDINGS NOW
0
AVG SELL PX
$91.89
TRADE KIND
SHOWING 85 / 85
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
16 backtested trades · 8 horizons · 6 pending
Forward-return performance of every backtestable P/S trade by James Herriott, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d16+56.25%+0.65%+0.53%+0.12%-0.41%
14d16+37.50%+0.22%+0.47%-0.25%+2.12%
30d16+37.50%+5.89%+1.66%+4.24%+3.43%
60d16+37.50%+7.37%+2.56%+4.81%+0.62%
90d16+50.00%+6.99%+4.28%+2.70%-7.75%
180d16+46.15%+3.55%+9.43%-6.78%-6.68%
1y16(3 pending)+100.00%-21.94%+23.48%-45.42%-39.36%
2y16(3 pending)+58.33%+11.92%+43.97%-31.89%-74.97%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
EXAS · 0 shares · as of Mar 23, 2026
018,73337,46756,20074,933202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 33 buys / 52 sellsCOVERAGE · 13 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
7930Mar 23, 2026Mar 23, 2026View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
2,8610Mar 23, 2026Mar 23, 2026View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
1,7620Mar 23, 2026Mar 23, 2026View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
20,3210Mar 23, 2026Mar 23, 2026View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
68,1950Mar 23, 2026Mar 23, 2026View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
20,32120,321Feb 25, 2026Feb 27, 2026View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
7,995$101.82$814.1K38,501Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
7,118$101.82$724.8K67,815Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
30,28774,024Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
PURCHASE
SVP, General Counsel & Sec
3,78016,238Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
3,447$101.82$351.0K29,487Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
17,00946,496Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
PURCHASE
SVP, General Counsel & Sec
13,89332,934Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
15,14474,933Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
7,3340Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
PURCHASE
SVP, General Counsel & Sec
7,33432,934Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
3,349$101.82$341.0K18,237Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
7,1250Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
1,777$101.82$180.9K14,461Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
14,235$101.82$1.45M59,789Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
PURCHASE
SVP, General Counsel & Sec
7,12521,586Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
9,88048,381Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
13,8930Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
PURCHASE
SVP, General Counsel & Sec
1,64813,233Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
1,6480Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
4,644$101.82$472.9K43,737Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
6,530$101.82$664.9K25,600Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
3,7800Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
775$101.82$78.9K12,458Dec 23, 2025Dec 30, 2025View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
1,000$70.00$70.0K11,585Nov 19, 2025Nov 21, 2025View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
1,500$70.08$105.1K12,585Nov 4, 2025Nov 6, 2025View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
1,500$60.00$90.0K14,085Oct 9, 2025Oct 10, 2025View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
7,3347,334May 6, 2025May 8, 2025View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
363$38.26$13.9K15,585Apr 30, 2025May 8, 2025View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
1,117$47.82$53.4K15,222Feb 28, 2025Mar 4, 2025View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
2,3757,125Feb 28, 2025Mar 4, 2025View →
EXAS
EXACT SCIENCES CORP
PURCHASE
SVP, General Counsel & Sec
2,37516,339Feb 28, 2025Mar 4, 2025View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
1,8903,780Feb 28, 2025Mar 4, 2025View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
889$47.82$42.5K13,964Feb 28, 2025Mar 4, 2025View →
EXAS
EXACT SCIENCES CORP
PURCHASE
SVP, General Counsel & Sec
1,89014,853Feb 28, 2025Mar 4, 2025View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
775$51.28$39.7K12,963Feb 25, 2025Feb 26, 2025View →
EXAS
EXACT SCIENCES CORP
PURCHASE
SVP, General Counsel & Sec
1,64713,738Feb 25, 2025Feb 26, 2025View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
1,6471,648Feb 25, 2025Feb 26, 2025View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
13,89313,893Feb 24, 2025Feb 26, 2025View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
3,32413,622Feb 20, 2025Feb 21, 2025View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
1,531$50.48$77.3K12,091Feb 20, 2025Feb 21, 2025View →
EXAS
EXACT SCIENCES CORP
PURCHASE
SVP, General Counsel & Sec
86510,731Feb 19, 2025Feb 21, 2025View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
8650Feb 19, 2025Feb 21, 2025View →
EXAS
EXACT SCIENCES CORP
SALE
SVP, General Counsel & Sec
433$49.63$21.5K10,298Feb 19, 2025Feb 21, 2025View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
30$60.15$1.8K9,866May 1, 2024May 2, 2024View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
708$30.02$21.3K9,896Apr 30, 2024May 2, 2024View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
639,188Apr 30, 2024May 2, 2024View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
862$59.32$51.1K9,125Mar 1, 2024Mar 4, 2024View →
EXAS
EXACT SCIENCES CORP
SALE
General Counsel
1,8905,670Feb 29, 2024Mar 4, 2024View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Counsel
1,8909,987Feb 29, 2024Mar 4, 2024View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
784$56.89$44.6K8,097Feb 27, 2024Feb 28, 2024View →
EXAS
EXACT SCIENCES CORP
SALE
General Counsel
1,6483,295Feb 26, 2024Feb 28, 2024View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
9,5009,500Feb 26, 2024Feb 28, 2024View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Counsel
1,6488,881Feb 26, 2024Feb 28, 2024View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
291$59.78$17.4K7,233Feb 22, 2024Feb 23, 2024View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
415$61.50$25.5K6,943Feb 21, 2024Feb 22, 2024View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
5817,524Feb 21, 2024Feb 23, 2024View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Counsel
8647,358Feb 20, 2024Feb 22, 2024View →
EXAS
EXACT SCIENCES CORP
SALE
General Counsel
8640Feb 20, 2024Feb 22, 2024View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
421$61.43$25.9K6,494Feb 15, 2024Feb 16, 2024View →
EXAS
EXACT SCIENCES CORP
SALE
General Counsel
8830Feb 14, 2024Feb 16, 2024View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Counsel
8836,915Feb 14, 2024Feb 16, 2024View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
68$30.02$2.0K6,032Oct 31, 2023Feb 16, 2024View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
1,300$100.00$130.0K5,964Jul 19, 2023Jul 21, 2023View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
1,300$90.00$117.0K7,264Jun 8, 2023Jun 12, 2023View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
1,300$79.85$103.8K8,564May 10, 2023May 12, 2023View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
640$30.02$19.2K9,864May 1, 2023May 12, 2023View →
EXAS
EXACT SCIENCES CORP
SALE
General Counsel
1,350$59.98$81.0K10,099Feb 28, 2023Mar 1, 2023View →
EXAS
EXACT SCIENCES CORP
SALE
General Counsel
875$61.12$53.5K9,224Feb 28, 2023Mar 1, 2023View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Counsel
24011,449Feb 27, 2023Mar 1, 2023View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Counsel
1,64711,209Feb 27, 2023Mar 1, 2023View →
EXAS
EXACT SCIENCES CORP
SALE
General Counsel
1,6474,943Feb 27, 2023Mar 1, 2023View →
EXAS
EXACT SCIENCES CORP
SALE
General Counsel
2400Feb 27, 2023Mar 1, 2023View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
7,5607,560Feb 24, 2023Feb 28, 2023View →
EXAS
EXACT SCIENCES CORP
SALE
General Counsel
398$62.72$25.0K9,562Feb 22, 2023Feb 23, 2023View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Counsel
8659,960Feb 21, 2023Feb 23, 2023View →
EXAS
EXACT SCIENCES CORP
SALE
General Counsel
8651,728Feb 21, 2023Feb 23, 2023View →
EXAS
EXACT SCIENCES CORP
SALE
General Counsel
400$65.59$26.2K9,095Feb 15, 2023Feb 16, 2023View →
EXAS
EXACT SCIENCES CORP
SALE
General Counsel
883883Feb 14, 2023Feb 16, 2023View →
EXAS
EXACT SCIENCES CORP
PURCHASE
General Counsel
8839,495Feb 14, 2023Feb 16, 2023View →
Other insiders · EXAS
Loading peer insiders…
About this filer
CIK 0001957680
ROLE
SVP, General Counsel & Sec
PRIMARY
EXAS
COMPANIES
1
ACTIVE SINCE
Feb 2023
MARKETPEEL · /INSIDER/0001957680DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback